rocuronium bromide Vials, injection 50 mg / 5 ml

Dossier type
Dossier status
Ready to file
Country of origin
GMP approvals
Manufacturer #18588
The company's main business is distributors of medications and druggists' sundries, as well as connected activities. It has been doing business in Latin America since the 2000s. It brings in about $8 million in revenue. Specialists in the therapeutic areas of cardiology, anti-infectives, anesthetics, respiratory, and antidotes who attend very difficult services.

Manufacturer usually replies in 25 days


Rocuronium Bromide is an amino steroid non-depolarizing neuromuscular blocker. It is used as a muscle relaxant in anaesthesia to facilitate tracheal intubation by providing skeletal muscle relaxation. It is commonly required for surgery or mechanical ventilation. This injection is given both inpatients and outpatients in combination with general anaesthesia. It facilitates both rapid sequence and routine tracheal intubation and relaxes skeletal muscles during surgeries or mechanical ventilation.

Rocuronium Bromide is sold under the brand names Zemuron and Esmeron among others. Akzo N.V. was the file company file a patent for preparation for Rocuronium Bromide in the late 1908s. However, it was only approved for use in the USA in 1994 and is marketed under the trade name of Zemuron. However, this medicine was subsequently withdrawn for its use in executions of death row convicts.

Usage and Dosage:

Rocuronium Bromide is only available as an injection. In cases when the patient needs Tyrachael intubation, they are recommended an initial dose of, regardless of the anaesthetic technique, 0.6 mg per kilo of body weight. In some case, a lower dose of 0.45 mg may also be prescribed. Each ML of this injection has 10 mg of Rocuronium bromide and 2 mg of sodium acetate. For patients who need Rapid Sequence Intubation, in case of properly pre-medicated and anaesthetized patients, the recommended dose is 0.6 to 1.2 mg per kilo of body weight. It can provide excellent conditions for intubating most patients within 2 minutes. When being administered as a Continuous Infusion, the initial infusion rate is 10 to 12 mcg per kilo per minute.

The price of Rocuronium Bromide:

In the USA, the consumers have to pay an average retail price of $ 0.65 for a supply of one injection with a 10 ml supply of this injection. The price of significantly cheaper in the developing, for example in India, the cost of a 5ml supply of this medicine will cost less than USD2.

How does Rocuronium Bromide work?

Rocuronium bromide has a rapid onset and an intermediate duration of action. It was made to be a weaker antagonist at the neuromuscular junction than pancuronium. So, its monoquaternary structure and groups attached to I D ring quaternary nitrogen atom. Rocuronium actions compete for cholinergic receptors at the motor endplate. Antagonized by acetylcholinesterase inhibitors, such as neostigmine and edrophonium, its actions competitively binding to nicotinic cholinergic receptors.

Finding Rocuronium bromide Manufacturers and Suppliers:

The best way to find and gain access to Rocuronium bromide manufacturers and Rocuronium bromide suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Rocuronium bromide can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Rocuronium bromide to work with. You can fine-tune your search results using various filters too, letting you search for Rocuronium bromide from specific countries.